| Key features and details | |
| Cat. No. | MABL-3448 | 
| Name | Anti-CTLA-4 [9D9](MABL-3448) | 
| Clone No. | 9D9 | 
| From | Recombinant Antibody | 
| Isotype | Engineer antibody | 
| Application | Block, IF | 
| Species Reactivity | Mouse | 
| Basic Information | |
| Specificity | The antibody is specific for CTLA-4. | 
| Alternative Name | CD152; CTLA4; Cytotoxic T-Lymphocyte Associated Protein 4; Insulin- Dependent Diabetes Mellitus 12; Celiac Disease 3; Ligand And Transmembrane Spliced Cytotoxic T Lymphocyte Associated Antigen 4; Cytotoxic T Lymphocyte Associated Antigen 4 Short Spliced Fo | 
| UniProt | P09793 | 
| Immunogen | The antibody was raised against CTLA-4. | 
| Application Notes | The antibody has been used to block CTLA-4 and has been shown to enhance T-cell immunity against tumours (Quezada et al, 2006). 9D9 also has an anti-B16/BL6 melanoma effect in non- irradiated tumour-bearing recipients when given as combinatorial therapy with Gvax (Peggs et al, 2009). Selby et al. (PMID: 24777248) show how conversion of the original mouse IgG2b to a mouse IgG2a greatly increases anti-tumor activity of the 9D9 antibody in both MC38 (C57BL/6 mice) and CT26 (BALB/c mice) models. This mechanism both involves blockade of CTLA4 as well as depletion of tumor-infiltrating regulatory T-cells. Fc Silent antibodies were shown to have reduced anti-tumor activity as they did not deplete tumor infiltrating regulatory T-cells, however they lead to expansion of peripheral Tregs. | 
| Antibody First Published | Simpson T et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma J Exp Med. 2013 Aug 26; 210(9): 1695–1710. PMID:23897981 | 
| Note on publication | Describes the characterisation of the Fcγ receptor-dependent activity of 9D9 on the T reg cell compartment. | 
| COA Information (For reference only, actual COA shall prevail) | |
| Size | 100 μg Purified antibody. | 
| Concentration | 1 mg/ml. | 
| Purification | Protein A affinity purified | 
| Buffer | PBS with 0.02% Proclin 300. | 
| Concentration | 1 mg/ml. | 
| Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. | 

 
  



